By |

Profile

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

Contact Information

Website: www.advaxis.com
Email: mmiller@lhai.com
Main Phone: +1 609 452-9813
Address: 305 College Road East
State: NJ
City / Town: Princeton
Country: USA
Postal Code: 8540

Issuer Information

Exchange: NGS
CEO: Kenneth A. Berlin
Employees: 58
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

Contact Information

Website: www.advaxis.com
Email: mmiller@lhai.com
Main Phone: +1 609 452-9813
Address: 305 College Road East
State: NJ
City / Town: Princeton
Country: USA
Postal Code: 8540

Issuer Information

Exchange: NGS
CEO: Kenneth A. Berlin
Employees: 58
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 2.93 $ 0. (0.00%)
Last Price 2.93 Change $ 0. Change % 0.00 Tick N/A
Bid 2.91 Bid Size 1,000.00 Ask 2.95 Ask Size 1,500.00
Open 2.89 High 2.96 Low 2.86 Prev Close 2.93
Last Trade Volume 19,177 52 Wk Hi 29.40 52 Wk Low 2.72
Market Cap 23.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 8,006,984.00 EPS (TTM) -9.75 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 34
Number of Buys 3 24
Number of Sells 2 10
Net Activity -9671 253572
Last 10 Buys Shares
Daniel J. O'Connor 1,000
Roni A. Appel 1,000
James Patton 1,000
Daniel J. O'Connor 1,000
Mark J. Rosenblum 1,000
Last 10 Sell Shares
Robert Petit 1,000
Anthony A. Lombardo 1,000
Sara Bonstein 1,000
Robert Petit 1,000
Sara Bonstein 1,000
Anthony A. Lombardo 1,000
Robert Petit 1,000
Sara Bonstein 1,000
Robert Petit 1,000
Sara Bonstein 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 5
Low Target Price Estimate 5 5 5 2
Mean Target Price Estimate 6.67 6.67 6.67 3.33
Standard Deviation 2.08 2.08 2.08 1.53
Date of Most Recent Estimate 03/14/18 03/14/18 03/14/18 06/13/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 3 3 3
Moderate Buy 0 0 0 0
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 1 1 1